ERBB3 and malignant colon neoplasm: In colon cancer cells, the activation of HER3 by its ligand heregulin strongly induces COX-2 expression and PGE2, thus leading to an increase in cell proliferation and motility via activation of the PI3K/Akt pathway [62, 63].